Plenty of Dexamethasone, Favipiravir stock with drugmakers: NPPA informs AIOCD
New Delhi: With details of specific medicine stock provided by the National Pharmaceutical Pricing Authority (NPPA), the chemist body, All India Organization of Chemists & Druggists (AIOCD), has recently directed all its Office Bearers, Presidents, Secretaries, and Executive Committee members to check the availability of the said drugs including Dexamethasone, Favipiravir, Ivermectin and Methylprednisolone Injection in their States, and ask their stockists to send orders to the companies if they don't have the said formulations.
AIOCD through its letter informed them that manufacturers have plenty of stock with their CFA and that it is requested to check the availability of COVID19 treatment.
The directive comes following a series of in-depth deliberations on the availability of some key medicines. At the beginning, the AIOCD had a Zone-by-Zone meeting with all office bearers to discuss the availability of medicines in the country. Thereafter, NPPA had a meeting with AIOCD where the report given by all states was submitted to the Government and concerned department.
In light of the above hearings, NPPA had discussed with the manufacturers of the following medicines and informed AIOCD that the below manufacturers have plenty of stock with their CFA.
Therefore, in the letter, it is urged, "You are therefore, requested to check the same in your state and ask your stockists to send orders for the below products to the companies if they don't have the said medicines as transpired in our meetings."
As a result of these measures, it is expected that any shortages of these drugs would be solved immediately.
The stock position of 'Dexamethasone' Injection with the major manufacturing Companies as on 07.05.2021 are as mentioned below:
Sr. No. | Company Name | Stock (Vials in Lakh) |
1 | M/s Cadila Healthcare | 165.49 |
2 | M/s Cadila Pharmaceuticals | 4.82 |
3 | M/s Wockhardt Limited | 15.99 |
Total | 186.30 |
In continuation to that, the letter also mentioned that it was observed that the major manufacturing/ marketing companies are having sufficient quantity of stock of other COVID Management Drugs.
Details of the manufacturer and the formulation are as under :
Sr. No | Drug name | Company Name | |
1 | Favipiravir Tablet | 1) M/s Glenmark Pharmaceuticals Limited | |
2) M/s Pure and Cure Healthcare Pvt. Ltd | |||
3) M/s Optimum Pharma | |||
4) M/s Macleods Pharmaceuticals Limited | |||
5) M/s BDR Pharmaceuticals Internationals Pvt. Ltd | |||
6) M/s Sun Pharmaceuticals Industries Ltd. | |||
2 | lvermectin Tablet | 1) M/s Sun Pharmaceuticals Industries Ltd | |
12) Akums Drugs & Pharmaceutical Ltd. | |||
13) M/s lnnova Captab Lt d. | |||
14) M/s Mankind Pharma | |||
15) M/s Sano Cito therapeutics (India) Ltd. | |||
' 6) | M/s Windlas Biotech Private Lt d. | ||
) | M/s Penta Kraft | ||
3 | Methylprednisolone Injection | 1) M/s Sun Pharmaceuticals Industries Ltd | |
2) M/s Neon Laboratories Lt d. | |||
13) M/s Aqua Vitoe Laboratories | |||
) M/s Pfizer India | |||
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.